JP2014528696A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014528696A5 JP2014528696A5 JP2014517736A JP2014517736A JP2014528696A5 JP 2014528696 A5 JP2014528696 A5 JP 2014528696A5 JP 2014517736 A JP2014517736 A JP 2014517736A JP 2014517736 A JP2014517736 A JP 2014517736A JP 2014528696 A5 JP2014528696 A5 JP 2014528696A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- peptide
- psca
- amino acid
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 8
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 7
- 150000001413 amino acids Chemical class 0.000 claims description 6
- 230000027455 binding Effects 0.000 claims description 3
- 101000972485 Homo sapiens Lupus La protein Proteins 0.000 claims description 2
- 102000052972 human La Human genes 0.000 claims description 2
- 239000012636 effector Substances 0.000 description 8
- 101001136592 Homo sapiens Prostate stem cell antigen Proteins 0.000 description 6
- 102100036735 Prostate stem cell antigen Human genes 0.000 description 6
- 108010032595 Antibody Binding Sites Proteins 0.000 description 4
- 238000001514 detection method Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 230000000139 costimulatory effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102011118022.6 | 2011-06-30 | ||
| DE102011118022.6A DE102011118022B4 (de) | 2011-06-30 | 2011-06-30 | Antikörper gegen das Prostata-spezifische Stammzellenantigen und dessen Verwendung |
| PCT/EP2012/062716 WO2013001065A1 (de) | 2011-06-30 | 2012-06-29 | Antikörper gegen das prostata-spezifische stammzellantigen und dessen verwendung |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017002983A Division JP6549622B2 (ja) | 2011-06-30 | 2017-01-12 | 前立腺特異幹細胞抗原に対する抗体およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014528696A JP2014528696A (ja) | 2014-10-30 |
| JP2014528696A5 true JP2014528696A5 (enExample) | 2015-10-01 |
Family
ID=46384405
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014517736A Pending JP2014528696A (ja) | 2011-06-30 | 2012-06-29 | 前立腺特異幹細胞抗原に対する抗体およびその使用 |
| JP2017002983A Expired - Fee Related JP6549622B2 (ja) | 2011-06-30 | 2017-01-12 | 前立腺特異幹細胞抗原に対する抗体およびその使用 |
| JP2019117977A Active JP6886491B2 (ja) | 2011-06-30 | 2019-06-26 | 前立腺特異幹細胞抗原に対する抗体およびその使用 |
| JP2021081553A Active JP7341185B2 (ja) | 2011-06-30 | 2021-05-13 | 前立腺特異幹細胞抗原に対する抗体およびその使用 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017002983A Expired - Fee Related JP6549622B2 (ja) | 2011-06-30 | 2017-01-12 | 前立腺特異幹細胞抗原に対する抗体およびその使用 |
| JP2019117977A Active JP6886491B2 (ja) | 2011-06-30 | 2019-06-26 | 前立腺特異幹細胞抗原に対する抗体およびその使用 |
| JP2021081553A Active JP7341185B2 (ja) | 2011-06-30 | 2021-05-13 | 前立腺特異幹細胞抗原に対する抗体およびその使用 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9200078B2 (enExample) |
| EP (2) | EP3505536B1 (enExample) |
| JP (4) | JP2014528696A (enExample) |
| AU (1) | AU2012277784B2 (enExample) |
| CY (1) | CY1121249T1 (enExample) |
| DE (1) | DE102011118022B4 (enExample) |
| DK (1) | DK2726507T3 (enExample) |
| ES (2) | ES2711978T3 (enExample) |
| HR (1) | HRP20190289T1 (enExample) |
| HU (1) | HUE042008T2 (enExample) |
| LT (1) | LT2726507T (enExample) |
| PL (1) | PL2726507T3 (enExample) |
| PT (1) | PT2726507T (enExample) |
| RS (1) | RS58448B1 (enExample) |
| SI (1) | SI2726507T1 (enExample) |
| SM (1) | SMT201900085T1 (enExample) |
| TR (1) | TR201901991T4 (enExample) |
| WO (1) | WO2013001065A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102011118022B4 (de) * | 2011-06-30 | 2018-01-18 | Gemoab Monoclonals Gmbh | Antikörper gegen das Prostata-spezifische Stammzellenantigen und dessen Verwendung |
| ES2688035T3 (es) | 2014-08-29 | 2018-10-30 | Gemoab Monoclonals Gmbh | Receptor de antígeno universal que expresa células inmunes para direccionamiento de antígenos múltiples diversos, procedimiento para fabricación del mismo y utilización del mismo para tratamiento de cáncer, infecciones y enfermedades autoinmunes |
| CA3053010A1 (en) | 2017-02-08 | 2018-08-16 | Dragonfly Therapeutics, Inc. | Multi-specific binding proteins for activation of natural killer cells and therapeutic uses thereof to treat cancer |
| JP7685821B2 (ja) | 2017-02-20 | 2025-05-30 | ドラゴンフライ セラピューティクス， インコーポレイテッド | Ｈｅｒ２、ＮＫＧ２ＤおよびＣＤ１６に結合するタンパク質 |
| WO2019066093A1 (ko) * | 2017-09-26 | 2019-04-04 | 주식회사 와이바이오로직스 | Scf 특이적 항체 |
| US11884733B2 (en) | 2018-02-08 | 2024-01-30 | Dragonfly Therapeutics, Inc. | Antibody variable domains targeting the NKG2D receptor |
| CA3090236A1 (en) | 2018-02-08 | 2019-08-15 | Dragonfly Therapeutics, Inc. | Combination therapy of cancer involving multi-specific binding proteins that activate natural killer cells |
| KR102832460B1 (ko) | 2018-02-20 | 2025-07-11 | 드래곤플라이 쎄라퓨틱스, 인크. | Cd33, nkg2d, 및 cd16에 결합하는 다중-특이적 결합 단백질, 및 이의 사용 방법 |
| MA53284A (fr) | 2018-08-08 | 2022-01-26 | Dragonfly Therapeutics Inc | Protéines de liaison à nkg2d, à cd16 et à un antigène associé à une tumeur |
| AU2019318083A1 (en) | 2018-08-08 | 2021-02-25 | Dragonfly Therapeutics, Inc. | Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of use |
| EA202091888A1 (ru) | 2018-08-08 | 2020-10-23 | Драгонфлай Терапьютикс, Инк. | Вариабельные домены антител, нацеленные на рецептор nkg2d |
| IL297922A (en) | 2020-05-06 | 2023-01-01 | Dragonfly Therapeutics Inc | Proteins binding nkg2d, cd16 and clec12a |
| CN116406381A (zh) * | 2020-05-19 | 2023-07-07 | 希望之城 | 工程化抗前列腺干细胞抗原融合蛋白及其用途 |
| CN117222663A (zh) | 2021-03-03 | 2023-12-12 | 蜻蜓疗法股份有限公司 | 使用结合nkg2d、cd16和肿瘤相关抗原的多特异性结合蛋白治疗癌症的方法 |
| WO2024233662A2 (en) * | 2023-05-09 | 2024-11-14 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Molecules that bind to psca polypeptides |
| US20250302763A1 (en) | 2024-02-22 | 2025-10-02 | Capstan Therapeutics, Inc. | Immune engineering amplification |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998040403A1 (en) * | 1997-03-10 | 1998-09-17 | The Regents Of The University Of California | Psca: prostate stem cell antigen |
| US6541212B2 (en) * | 1997-03-10 | 2003-04-01 | The Regents Of The University Of California | Methods for detecting prostate stem cell antigen protein |
| CN1413220A (zh) * | 1999-10-29 | 2003-04-23 | 杰南技术公司 | 抗前列腺干细胞抗原(psca)抗体组合物及其应用方法 |
| SI1673398T1 (sl) * | 2003-10-16 | 2011-05-31 | Micromet Ag | Multispecifiäśne deimunizirajoäśe cd3 povezovalne molekule |
| MXPA06013834A (es) * | 2004-05-28 | 2007-03-01 | Agensys Inc | Anticuerpos y moleculas relacionadas que enlazan a proteinas psca. |
| WO2009032949A2 (en) * | 2007-09-04 | 2009-03-12 | The Regents Of The University Of California | High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection |
| BRPI0919840B1 (pt) * | 2008-10-01 | 2023-02-28 | Amgen Research (Munich) Gmbh | Molécula de anticorpo de cadeia única biespecífica, seu uso, e composição farmacêutica que a compreende |
| US20110142811A1 (en) * | 2009-12-16 | 2011-06-16 | Deutsches Krebsforschungszentrum | Measles virus for the elimination of unwanted cell populations |
| DE102011118022B4 (de) * | 2011-06-30 | 2018-01-18 | Gemoab Monoclonals Gmbh | Antikörper gegen das Prostata-spezifische Stammzellenantigen und dessen Verwendung |
-
2011
- 2011-06-30 DE DE102011118022.6A patent/DE102011118022B4/de not_active Expired - Fee Related
-
2012
- 2012-06-29 LT LTEP12729996.4T patent/LT2726507T/lt unknown
- 2012-06-29 DK DK12729996.4T patent/DK2726507T3/en active
- 2012-06-29 SM SM20190085T patent/SMT201900085T1/it unknown
- 2012-06-29 HR HRP20190289TT patent/HRP20190289T1/hr unknown
- 2012-06-29 ES ES12729996T patent/ES2711978T3/es active Active
- 2012-06-29 HU HUE12729996A patent/HUE042008T2/hu unknown
- 2012-06-29 AU AU2012277784A patent/AU2012277784B2/en not_active Ceased
- 2012-06-29 ES ES18207370T patent/ES2989975T3/es active Active
- 2012-06-29 WO PCT/EP2012/062716 patent/WO2013001065A1/de not_active Ceased
- 2012-06-29 US US14/129,933 patent/US9200078B2/en active Active
- 2012-06-29 EP EP18207370.0A patent/EP3505536B1/de active Active
- 2012-06-29 JP JP2014517736A patent/JP2014528696A/ja active Pending
- 2012-06-29 SI SI201231523T patent/SI2726507T1/sl unknown
- 2012-06-29 TR TR2019/01991T patent/TR201901991T4/tr unknown
- 2012-06-29 EP EP12729996.4A patent/EP2726507B1/de active Active
- 2012-06-29 RS RS20190218A patent/RS58448B1/sr unknown
- 2012-06-29 PL PL12729996T patent/PL2726507T3/pl unknown
- 2012-06-29 PT PT12729996T patent/PT2726507T/pt unknown
-
2017
- 2017-01-12 JP JP2017002983A patent/JP6549622B2/ja not_active Expired - Fee Related
-
2019
- 2019-02-11 CY CY20191100176T patent/CY1121249T1/el unknown
- 2019-06-26 JP JP2019117977A patent/JP6886491B2/ja active Active
-
2021
- 2021-05-13 JP JP2021081553A patent/JP7341185B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014528696A5 (enExample) | ||
| JP2016519932A5 (enExample) | ||
| AR111361A1 (es) | Anticuerpos biespecíficos de unión específica a pd1 y lag3 | |
| US8618247B2 (en) | Peptide, use of the peptide, method for the production of the peptide, solid support having the peptide immobilized thereon, and method for production of the solid support | |
| RU2015152077A (ru) | Тримерные антигенсвязывающие молекулы | |
| JP2019519227A5 (enExample) | ||
| JPWO2016186206A1 (ja) | ＩｇＧ結合ペプチドによる抗体の特異的修飾 | |
| CN102892885B (zh) | IgA结合性肽以及利用其的IgA的纯化 | |
| NZ701444A (en) | Antibodies to matrix metalloproteinase 9 | |
| JP2016531924A5 (enExample) | ||
| JP2020516603A5 (enExample) | ||
| JP2016508143A5 (enExample) | ||
| Okochi et al. | Array-based rational design of short peptide probe-derived from an anti-TNT monoclonal antibody | |
| Mehaffey et al. | Mapping a conformational epitope of hemagglutinin A using native mass spectrometry and ultraviolet photodissociation | |
| CN105473606A (zh) | 具有突变的支架的结合多肽 | |
| WO2014144911A3 (en) | Hybrid immunoglobulin containing non-peptidyl linkage | |
| WO2012126118A8 (en) | Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy | |
| Xiao et al. | Nanobody in a Double “Y”-Shaped Assembly: A Promising Candidate for Lateral Flow Immunoassays | |
| EA201100741A1 (ru) | Антитела к модифицированным пептидам ифр-1/е человека | |
| JP6103772B2 (ja) | ＩｇＡ結合性ペプチド及びそれによるＩｇＡの精製 | |
| JP2009278927A (ja) | Ｔ細胞受容体を模倣する抗体断片及びその製造方法 | |
| Hortigüela et al. | Engineering recombinant antibodies for polymer biofunctionalization | |
| JP7095899B2 (ja) | 結合部位を決定するための方法およびキット | |
| JP2016002009A (ja) | タグ付抗体 | |
| KR101300187B1 (ko) | 융합 단백질 및 이를 포함하는 바이오센서 |